Global Breast Cancer Therapeutics Market 2022-2026

The publisher has been monitoring the breast cancer therapeutics market and it is poised to grow by $13.85 billion during 2022-2026, accelerating at a CAGR of 8.95% during the forecast period. This report on the breast cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

This report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of breast cancer, robust pipeline and new drug approvals, and rising number of patient support initiatives.

The breast cancer therapeutics market analysis includes the product segment and geographic landscape,

The publisher's breast cancer therapeutics market is segmented as below:

By Product

Targeted therapy
Hormonal therapy
Chemotherapy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the emerging novel therapies as one of the prime reasons driving the breast cancer therapeutics market growth during the next few years. Also, the availability of improved diagnostic modalities and the rise in strategic collaborations will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. This report on the breast cancer therapeutics market covers the following areas:

Breast cancer therapeutics market sizing
Breast cancer therapeutics market forecast
Breast cancer therapeutics market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast cancer therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Clovis Oncology Inc., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Kyowa Kirin Co. Ltd., Merck and Co. Inc., Novartis AG, PerkinElmer Inc., Pfizer Inc., Puma Biotechnology Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the breast cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 12: Market segments

3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026

Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary

Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers

Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers

Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026

4.4 Threat of new entrants

Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026

4.5 Threat of substitutes

Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026

4.6 Threat of rivalry

Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026

4.7 Market condition

Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments

Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

5.2 Comparison by Product

Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product

5.3 Targeted therapy - Market size and forecast 2021-2026

Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)

5.4 Hormonal therapy - Market size and forecast 2021-2026

Exhibit 32: Chart on Hormonal therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Hormonal therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Hormonal therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Hormonal therapy - Year-over-year growth 2021-2026 (%)

5.5 Chemotherapy - Market size and forecast 2021-2026

Exhibit 36: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)

5.6 Market opportunity by Product

Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview

Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation

Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)

7.2 Geographic comparison

Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026

Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026

Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026

Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026

Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026

Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026

Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 Canada - Market size and forecast 2021-2026

Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.10 UK - Market size and forecast 2021-2026

Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.11 China - Market size and forecast 2021-2026

Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity By Geographical Landscape

Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges

Exhibit 83: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape

Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption

Exhibit 85: Overview on factors of disruption

9.4 Industry risks

Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered

Exhibit 87: Vendors covered

10.2 Market positioning of vendors

Exhibit 88: Matrix on vendor position and classification

10.3 AbbVie Inc.

Exhibit 89: AbbVie Inc. - Overview
Exhibit 90: AbbVie Inc. - Product/Service
Exhibit 91: AbbVie Inc. - Key offerings

10.4 Amgen Inc.

Exhibit 92: Amgen Inc. - Overview
Exhibit 93: Amgen Inc. - Product/Service
Exhibit 94: Amgen Inc. - Key offerings

10.5 AstraZeneca Plc

Exhibit 95: AstraZeneca Plc - Overview
Exhibit 96: AstraZeneca Plc - Product/Service
Exhibit 97: AstraZeneca Plc - Key news
Exhibit 98: AstraZeneca Plc - Key offerings

10.6 Eli Lilly and Co.

Exhibit 99: Eli Lilly and Co. - Overview
Exhibit 100: Eli Lilly and Co. - Product/Service
Exhibit 101: Eli Lilly and Co. - Key offerings

10.7 F. Hoffmann La Roche Ltd.

Exhibit 102: F. Hoffmann La Roche Ltd. - Overview
Exhibit 103: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 104: F. Hoffmann La Roche Ltd. - Key news
Exhibit 105: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 106: F. Hoffmann La Roche Ltd. - Segment focus

10.8 GlaxoSmithKline Plc

Exhibit 107: GlaxoSmithKline Plc - Overview
Exhibit 108: GlaxoSmithKline Plc - Business segments
Exhibit 109: GlaxoSmithKline Plc - Key offerings
Exhibit 110: GlaxoSmithKline Plc - Segment focus

10.9 Kyowa Kirin Co. Ltd.

Exhibit 111: Kyowa Kirin Co. Ltd. - Overview
Exhibit 112: Kyowa Kirin Co. Ltd. - Product/Service
Exhibit 113: Kyowa Kirin Co. Ltd. - Key offerings

10.10 Novartis AG

Exhibit 114: Novartis AG - Overview
Exhibit 115: Novartis AG - Business segments
Exhibit 116: Novartis AG - Key offerings
Exhibit 117: Novartis AG - Segment focus

10.11 PerkinElmer Inc.

Exhibit 118: PerkinElmer Inc. - Overview
Exhibit 119: PerkinElmer Inc. - Business segments
Exhibit 120: PerkinElmer Inc. - Key news
Exhibit 121: PerkinElmer Inc. - Key offerings
Exhibit 122: PerkinElmer Inc. - Segment focus

10.12 Pfizer Inc.

Exhibit 123: Pfizer Inc. - Overview
Exhibit 124: Pfizer Inc. - Product/Service
Exhibit 125: Pfizer Inc. - Key news
Exhibit 126: Pfizer Inc. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist

Exhibit 127: Inclusions checklist
Exhibit 128: Exclusions checklist

11.3 Currency conversion rates for US$

Exhibit 129: Currency conversion rates for US$

11.4 Research methodology

Exhibit 130: Research methodology
Exhibit 131: Validation techniques employed for market sizing
Exhibit 132: Information sources

11.5 List of abbreviations

Exhibit 133: List of abbreviations

Exhibits:

Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Incremental Growth
Exhibit 7: Executive Summary - Data Table on Incremental Growth
Exhibit 8: Executive Summary - Chart on Vendor Market Positioning
Exhibit 9: Parent market
Exhibit 10: Market Characteristics
Exhibit 11: Offerings of vendors included in the market definition
Exhibit 12: Market segments
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
Exhibit 32: Chart on Hormonal therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Hormonal therapy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Hormonal therapy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Hormonal therapy - Year-over-year growth 2021-2026 (%)
Exhibit 36: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
Exhibit 40: Market opportunity by Product ($ million)
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
Exhibit 85: Overview on factors of disruption
Exhibit 86: Impact of key risks on business
Exhibit 87: Vendors covered
Exhibit 88: Matrix on vendor position and classification
Exhibit 89: AbbVie Inc. - Overview
Exhibit 90: AbbVie Inc. - Product/Service
Exhibit 91: AbbVie Inc. - Key offerings
Exhibit 92: Amgen Inc. - Overview
Exhibit 93: Amgen Inc. - Product/Service
Exhibit 94: Amgen Inc. - Key offerings
Exhibit 95: AstraZeneca Plc - Overview
Exhibit 96: AstraZeneca Plc - Product/Service
Exhibit 97: AstraZeneca Plc - Key news
Exhibit 98: AstraZeneca Plc - Key offerings
Exhibit 99: Eli Lilly and Co. - Overview
Exhibit 100: Eli Lilly and Co. - Product/Service
Exhibit 101: Eli Lilly and Co. - Key offerings
Exhibit 102: F. Hoffmann La Roche Ltd. - Overview
Exhibit 103: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 104: F. Hoffmann La Roche Ltd. - Key news
Exhibit 105: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 106: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 107: GlaxoSmithKline Plc - Overview
Exhibit 108: GlaxoSmithKline Plc - Business segments
Exhibit 109: GlaxoSmithKline Plc - Key offerings
Exhibit 110: GlaxoSmithKline Plc - Segment focus
Exhibit 111: Kyowa Kirin Co. Ltd. - Overview
Exhibit 112: Kyowa Kirin Co. Ltd. - Product/Service
Exhibit 113: Kyowa Kirin Co. Ltd. - Key offerings
Exhibit 114: Novartis AG - Overview
Exhibit 115: Novartis AG - Business segments
Exhibit 116: Novartis AG - Key offerings
Exhibit 117: Novartis AG - Segment focus
Exhibit 118: PerkinElmer Inc. - Overview
Exhibit 119: PerkinElmer Inc. - Business segments
Exhibit 120: PerkinElmer Inc. - Key news
Exhibit 121: PerkinElmer Inc. - Key offerings
Exhibit 122: PerkinElmer Inc. - Segment focus
Exhibit 123: Pfizer Inc. - Overview
Exhibit 124: Pfizer Inc. - Product/Service
Exhibit 125: Pfizer Inc. - Key news
Exhibit 126: Pfizer Inc. - Key offerings
Exhibit 127: Inclusions checklist
Exhibit 128: Exclusions checklist
Exhibit 129: Currency conversion rates for US$
Exhibit 130: Research methodology
Exhibit 131: Validation techniques employed for market sizing
Exhibit 132: Information sources
Exhibit 133: List of abbreviations

Executive Summary

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes the publisher's platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.